Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xin Gu

Showing results (711-720 of 727) with videos related to

Pageof 73
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 21, 2005
Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheadsBrett R Ullman, Teresa Aja, Ning Chen, et al.
Biomedical and Environmental Sciences : BES|October 12, 2010
Proteome analysis of Neisseria meningitidis serogroup strains C associated with outbreaks in ChinaYuan Hu, Zhu-Jun Shao, Xiao-Mei Yan, et al.
Journal of Medicinal Chemistry|May 26, 2021
Discovery of MK-8153, a Potent and Selective ROMK Inhibitor and Novel Diuretic/NatriureticJinlong Jiang, Fa-Xiang Ding, Xiaoyan Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2017
Improvement of hERG-ROMK index of spirocyclic ROMK inhibitors through scaffold optimization and incorporation of novel pharmacophoresShuzhi Dong, Kelsey VanGelder, Zhi-Cai Shi, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2024
Discovery of sulfone containing metallo-β-lactamase inhibitors with reduced bacterial cell efflux and histamine release issuesFrank Bennett, Yuhua Huang, Shuzhi Dong, et al.
Journal of the American Heart Association|March 4, 2026
ADJUVANT Randomized Controlled Trial: Rationale and DesignHongfei Sang, Zhilin Zheng, Heng Ni, et al.
Atherosclerosis|May 1, 2026
Enhanced risk for recurrent adverse cardiovascular events in homozygous carriers of the T-allele of CD40 SNP rs1883832Mark Colin Gissler, Johannes Neumann, Linlin Guo, et al.
Annals of Translational Medicine|November 4, 2020
Development and formulation of the classification criteria for osteoarthritisCibo Huang, Zhiyi Zhang, Yaolong Chen, et al.
Annals of Translational Medicine|January 13, 2021
Erratum to development and formulation of the classification criteria for osteoarthritisCibo Huang, Zhiyi Zhang, Yaolong Chen, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2016
Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffoldYuping Zhu, Reynalda K de Jesus, Haifeng Tang, et al.
Pageof 73

Showing results (711-720 of 727) with videos related to

Sort By:
Pageof 73
Bioorganic & Medicinal Chemistry Letters|June 21, 2005
Structure-activity relationships within a series of caspase inhibitors. Part 2: Heterocyclic warheadsBrett R Ullman, Teresa Aja, Ning Chen, et al.
Biomedical and Environmental Sciences : BES|October 12, 2010
Proteome analysis of Neisseria meningitidis serogroup strains C associated with outbreaks in ChinaYuan Hu, Zhu-Jun Shao, Xiao-Mei Yan, et al.
Journal of Medicinal Chemistry|May 26, 2021
Discovery of MK-8153, a Potent and Selective ROMK Inhibitor and Novel Diuretic/NatriureticJinlong Jiang, Fa-Xiang Ding, Xiaoyan Zhou, et al.
Bioorganic & Medicinal Chemistry Letters|April 23, 2017
Improvement of hERG-ROMK index of spirocyclic ROMK inhibitors through scaffold optimization and incorporation of novel pharmacophoresShuzhi Dong, Kelsey VanGelder, Zhi-Cai Shi, et al.
Bioorganic & Medicinal Chemistry Letters|October 13, 2024
Discovery of sulfone containing metallo-β-lactamase inhibitors with reduced bacterial cell efflux and histamine release issuesFrank Bennett, Yuhua Huang, Shuzhi Dong, et al.
Journal of the American Heart Association|March 4, 2026
ADJUVANT Randomized Controlled Trial: Rationale and DesignHongfei Sang, Zhilin Zheng, Heng Ni, et al.
Atherosclerosis|May 1, 2026
Enhanced risk for recurrent adverse cardiovascular events in homozygous carriers of the T-allele of CD40 SNP rs1883832Mark Colin Gissler, Johannes Neumann, Linlin Guo, et al.
Annals of Translational Medicine|November 4, 2020
Development and formulation of the classification criteria for osteoarthritisCibo Huang, Zhiyi Zhang, Yaolong Chen, et al.
Annals of Translational Medicine|January 13, 2021
Erratum to development and formulation of the classification criteria for osteoarthritisCibo Huang, Zhiyi Zhang, Yaolong Chen, et al.
Bioorganic & Medicinal Chemistry Letters|November 15, 2016
Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffoldYuping Zhu, Reynalda K de Jesus, Haifeng Tang, et al.
Pageof 73